[The cardiorenal syndrome and optimal treatment of renal anemia].
The cardiorenal syndrome is a clinical and pathophysiological concept illustrating the relationship between the two organs, and is mainly based on the control of volemia. Heart failure is an example of this entity: when congestive heart failure becomes refractory, ultrafiltration by various modes of dialysis is needed. Ambulatory peritoneal ultrafiltration is a good alternative for the management of treatment-resistant congestive heart failure. Erythropoietin is the main treatment of anaemia of chronic renal failure for dialysed and predialysed patients, or patients with congestive heart failure and renal insufficiency. Correction of anaemia needs to be controlled at a maximal haemoglobin level of 12 g/dl.
Bovy
P
P
Service de Néphrologie-Dialyse, CHC Saint-Joseph, Liège, Belgique.
Chachati
A
A
Godon
E
E
Ait-Oile
F
F
Bellavia
S
S
D018798:Anemia, Iron-Deficiency / Q000188:drug therapy / Q000503:physiopathology*; D002986:Clinical Trials as Topic; D004921:Erythropoietin / Q000627:therapeutic use; D006333:Heart Failure / Q000503:physiopathology*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007676:Kidney Failure, Chronic / Q000503:physiopathology*
D006454:Hemoglobins; D004921:Erythropoietin